Gene expression analysis of high-grade dysplasia revealed new molecular mechanism of disease
Gastroenterology and Hepatology from Bed to Bench,
Vol. 11 No. Supplement 1 (2018),
11 December 2018
,
Page s111-s117
https://doi.org/10.22037/ghfbb.v0i0.1542
Abstract
Aim: The aim of this research was to find a clear molecular view of dysplasia via network analysis.
Background: There are some evidence suggest the relationship between dysplasia and colorectal cancer. Understanding of high-grade dysplasia (HGD) could be beneficial for colon cancer management.
Methods: Bioinformatics study of HGD versus healthy subjects was conducted to check the status of differentially expressed genes (DEGs). GSE31106, GPL1261, GSM770092-94 and GSM770101-6 were the sources from gene expression omnibus (GEO) that queried for protein-protein interaction (PPI) network analysis via Cytoscape and its algorithms. Hubs of network were enriched for biochemical pathways and were validated via clustering analysis.
Results: Numbers of 46 hub nodes were determined and were included in 12 pathways. A main cluster including 76 nodes was identified containing 45 hubs. 33 hubs among 46 genes were involved in biochemical pathways. IL1B, IL6, TNF, and TRL4 were the most important critical genes.
Conclusion: Many different genes as hub nodes might influence the trigger and development of advance condition and also colon cancer.
Keywords: Transcriptome, Interactome, Colon cancer, High grade dysplasia.
(Please cite as: Malekpour H, Heidari MH, Vafaee R, Moravvej Farshi H, Khodadoostan M. Gene expression analysis of colon high-grade dysplasia revealed new molecular mechanism of disease. Gastroenterol Hepatol Bed Bench 2018;11(Suppl. 1):S111-S117).
- Transcriptome
- Interactome
- Colon cancer
- High grade dysplasia.
How to Cite
References
Hartmans E, Orian-Rousseau V, Matzke-Ogi A, Karrenbeld A, de Groot DJA, de Jong S, et al. Functional genomic mRNA profiling of colorectal adenomas: identification and in vivo validation of CD44 and splice variant CD44v6 as molecular imaging targets. Theranostics 2017;7:482.
Bashizadeh-Fakhar H, Rezaie-Tavirani M, Zali H, Faraji R, Nejad EK, Aghazadeh M. The Diagnostic Value of Serum CEA, CA-125, and ROMA Index in Low-Grade Serous Ovarian Cancer. Int J Cancer Manag 2018;11:e63397.
Larki P, Gharib E, Yaghoob Taleghani M, Khorshidi F, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H. Coexistence of KRAS and BRAF Mutations in Colorectal Cancer: A Case Report Supporting The Concept of Tumoral Heterogeneity. Cell J. 2017;19:113-117.
Sharifian A, Pourhoseingholi MA, Emadedin M, Rostami Nejad M, Ashtari S, Hajizadeh N, et al. Burden of Breast Cancer in Iranian Women is Increasing. Asian Pac J Cancer Prev. 2015;16:5049-52.
Mansouri V, Zadeh-Esmaeel M-M, Rostami-Nejad M, Rezaei–Tavirani M. Comparative study of gastric cancer and chronic gastritis via network analysis. Gastroenterol Hepatol Bed Bench 2018;11:343-51.
Koushki M, Atan NAD, Omidi-Ardali H, Tavirani MR. Assessment of Correlation Between miR-210 Expression and Pre-Eclampsia Risk: A Meta-Analysis. Rep Biochem Mol Biol 2018;7:94-101.
Rezaei–Tavirani M, Tavirani SR, Rostami FT. Biochemical pathway analysis of gastric atrophy. Gastroenterol Hepatol Bed Bench 2018;11:118-24.
Eesteghamati A, Gouya M, Keshtkar A, Najafi L, Zali MR, Sanaei M, et al. Sentinel hospital-based surveillance of rotavirus diarrhea in iran. J Infect Dis. 2009;200:S244-47.
Zhi J, Sun J, Wang Z, Ding W. Support vector machine classifier for prediction of the metastasis of colorectal cancer. Int J Mol Med 2018;41:1419-26.
Safari-Alighiarloo N, Rezaei-Tavirani M, Taghizadeh M, Tabatabaei SM, Namaki S. Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. Peer J 2016;4:e2775.
Nazemalhosseini Mojarad E, Kuppen PJ, Aghdaei HA, Zali MR. The CpG island methylator phenotype (CIMP) in colorectal cancer. Gastroenterol Hepatol Bed Bench. 201;6:120-8.
Azodi MZ, Rezaei-Tavirani M, Nejad MR, Rezaei-Tavirani M. Human Prolactinoma: A View of Protein-Protein Interaction Pattern. Int J Endocrinol Metab 2018;16:e67332
Kraus S, Arber N. Inflammation and colorectal cancer. Current opinion in pharmacology 2009;9:405-10.
Watt SK, Hasselbalch HC, Skov V, Kjær L, Thomassen M, Kruse TA, et al. Whole Blood Gene Expression Profiling in patients undergoing colon cancer surgery identifies differential expression of genes involved in immune surveillance, inflammation and carcinogenesis. Surg Oncol 2018;27:208-15.
Principe DR, DeCant B, Mangan RJ, Wayne EA, Diaz AM, Vitello D, et al. TGFβ signaling deficiency enhances tumor associated inflammation in colon cancer AACR; 2015.
Rostami Nejad M, Rostami K, Cheraghipour K, Nazemalhosseini Mojarad E, Volta U, Al Dulaimi D, et al. Celiac disease increases the risk of Toxoplasma gondii infection in a large cohort of pregnant women. Am J Gastroenterol. 2011;106:548-9.
Tang Z, Yuan S, Hu Y, Zhang H, Wu W, Zeng Z, et al. Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester. J Bioenerg Biomembr 2012;44:117-25.
Tarze A, Deniaud A, Le Bras M, Maillier E, Mollé D, Larochette N, et al. GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 2007;26:2606.
Sirover MA. GAPDH: A Multifunctional Moonlighting Protein in Eukaryotes and Prokaryotes. Moonlighting Proteins: Novel Virulence Factors in Bacterial Infections 2017:147-67.
Sirover MA. Pleiotropic effects of moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cancer progression, invasiveness, and metastases. Cancer Metastasis Rev 2018:1-12.
Tajbakhsh M, García Migura L, Rahbar M, Svendsen CA, Mohammadzadeh M, et al. Antimicrobial-resistant Shigella infections from Iran: an overlooked problem? J Antimicrob Chemother. 2012;67:1128-33.
Knüpfer H, Preiss R. Serum interleukin-6 levels in colorectal cancer patients—a summary of published results. Int J Colorectal Dis 2010;25:135-40.
Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Molecular cancer 2012;11:87.
Yesudhas D, Gosu V, Anwar MA, Choi S. Multiple roles of toll-like receptor 4 in colorectal cancer. Front Immunol 2014;5:334.
Nazemalhosseini Mojarad E, Farahani RK, Haghighi MM, Aghdaei HA, Kuppen PJ, Zali MR. Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol Bed Bench. 2013;6:6-13.
Norouzinia M, Asadzadeh H, Shalmani HM, Al Dulaimi D, Zali MR. Clinical and histological indicators of proximal and distal gastric cancer in eight provinces of Iran. Asian Pac J Cancer Prev. 2012;13:5677-79.
Zamanian Azodi M, Peyvandi H, Rostami-Nejad M, Safaei A, Rostami K, Vafaee Ret al. Protein-protein interaction network of celiac disease. Gastroenterol Hepatol Bed Bench. 2016;9:268-277.
- Abstract Viewed: 104 times
- PDF Downloaded: 98 times